62 results
8-K
EX-99.2
BLPH
Bellerophon Therapeutics, Inc.
5 Jun 23
Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
8:08am
2023 8 Overall Safety profile was balanced REBUILD Safety Assessment Safety analysis based on all subjects who received at least one dose post
424B5
r7gqisk2va3iervl 7ph
31 May 23
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
0c10807q a9f4vl839wj
5 Jan 22
Company Presentation I January 2022Bellerophon Therapeutics
8:39am